glp 1 and leg pain TrimRX GLP-1 peripheral artery disease -
Description
has participated in sponsored studies by Eli Lilly, MSD, Novo Nordisk, Novartis and Sanofi Aventis
Patients with missing demographic data (age or sex), type 1 DM, 30, missing baseline eGFR data, and those with a follow-up period 50%, and progression to ESKD with dialysis
Researchers collected data on weight change for up to 72 weeks
Future Med Chem (2015) 7(8):107989
Future research should investigate the underlying mechanisms that mediate these effects
Always check your vial concentration before converting
